CancerDrs

Liver Cancer clinical trials in Nevada

5 actively recruiting liver cancer trials at 2 sites across Nevada.

Data from ClinicalTrials.gov · last refreshed

Phase 1, Phase 2 Recruiting Industry

Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

The purpose of this study is to learn about the effects of study medicine (PF-08634404) when given alone or with another antibody (ipilimumab) for the treatment of a type of liver cancer called hepatocellular carcinoma (HCC) that is either…

Sponsor: Pfizer
NCT ID: NCT07227012
Sites in Nevada:
  • Renown Health Medical Oncology — Reno, Nevada
  • Renown Office of Clinical Research — Reno, Nevada
  • Renown Regional Medical Center — Reno, Nevada
View on ClinicalTrials.gov →
Phase 1 Recruiting Industry

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

This is a multicenter Phase 1b, open label, dose-escalation and cohort-expansion study, evaluating the safety, tolerability, pharmacokinetics (PK), preliminary antitumor activity, and effect of biomarkers of zanzalintinib administered alon…

Sponsor: Exelixis
NCT ID: NCT05176483
Sites in Nevada:
  • Exelixis Clinical Site #55 — Las Vegas, Nevada
View on ClinicalTrials.gov →
Recruiting Industry

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

The goal of this observational study is to collect information on the use of the HistoSonics Edison System for the treatment of liver tumors. The main aim is to understand how different patient characteristics and procedural characteristic…

Sponsor: HistoSonics, Inc.
NCT ID: NCT06486454
Sites in Nevada:
  • Renown Regional Medical Center — Reno, Nevada
View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-07-27